Madeline Pharmaceuticals Private Limited

Madeline Pharmaceuticals Private Limited - chemicals in Thane, Maharashtra, India. Directors, charges & compliance details.
CIN U24230MH2022PTC391294 Incorporated 28 September 2022 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2025
₹33.1 Lakh
▲ 114% YoY
Net profit · FY 2025
₹30,422
Net margin 0.9%
EBITDA · FY 2025
₹7.6 Lakh
EBITDA margin 23%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Madeline Pharmaceuticals Private Limited

Data last updated:

Madeline Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 28 September 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2022PTC391294.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Shrivastava and Vimal Kumar Shukla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B 104 Bhagwati Aprt Chs Ltd Navghar Cross Road 3 Gopinath Complex Bhayander, Thane, Maharashtra, India – 401105.

As per the financials filed for FY 2025, the company reported a revenue of ₹33.1 Lakh, a growth of 114% compared to the previous year. For the same year it recorded a net profit of ₹30,422 (net margin 0.9%) and EBITDA of ₹7.6 Lakh (EBITDA margin 23%).

Madeline Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-39-0012991). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230MH2022PTC391294
Registration Number 391294
Incorporation Date 28 September 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-39-0012991

Recognitions & Rankings of Madeline Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-UP-39-0012991

Contact details

Madeline Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra.

  • Registered Address
    B 104 Bhagwati Aprt Chs Ltd Navghar Cross Road 3 Gopinath Complex Bhayander, Thane, Maharashtra, India – 401105
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Madeline Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Madeline Pharmaceuticals is manufacturing. In detail, this covers manufacture of other non-metallic mineral products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing23Manufacture of other non-metallic mineral products

To see the full business activity and turnover split of Madeline Pharmaceuticals Private Limited, buy the company report.

Financials of Madeline Pharmaceuticals Private Limited

FY 2025 filings available

Madeline Pharmaceuticals Private Limited reported revenue of ₹33.1 Lakh (up 114% YoY) for FY 2025.

Revenue · FY 2025
₹33.1 Lakh ▲ 114%
Net profit · FY 2025
₹30,422 margin 0.9%
EBITDA · FY 2025
₹7.6 Lakh margin 23%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 114%
EBITDA CAGR growth
1 year
▲ 653%

Revenue rose 114% in the latest year. EBITDA rose 653% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.6 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹30,422
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin23%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Madeline Pharmaceuticals Private Limited, buy the company report.

Board of directors of Madeline Pharmaceuticals Private Limited

Madeline Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Prashant ShrivastavaDirector28 Sep 20224 Years 1 MonthsCurrent
Vimal Kumar ShuklaDirector28 Sep 20224 Years 1 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Madeline Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Madeline Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Madeline Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Prashant Shrivastava was appointed as Director on 28 Sep 2022.

AGM
Madeline Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Madeline Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Prashant Shrivastava was appointed as Director.
Appointed
Vimal Kumar Shukla was appointed as Director.
Incorporation
28 Sep 2022
Madeline Pharmaceuticals Private Limited was registered on 28 Sep 2022 with Roc Mumbai & aged 4 years 1 month as per MCA records.

Frequently asked questions

Madeline Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 28 September 2022 (4+ years old) and is registered under CIN U24230MH2022PTC391294.

Madeline Pharmaceuticals has 2 current directors:

The latest financial statements of Madeline Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Madeline Pharmaceuticals is U24230MH2022PTC391294. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Madeline Pharmaceuticals was incorporated on 28 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Prashant Shrivastava was appointed as Director on 28 Sep 2022. Vimal Kumar Shukla was appointed as Director on 28 Sep 2022.

Yes, Madeline Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-39-0012991).

The registered office of Madeline Pharmaceuticals is at B 104 Bhagwati Aprt Chs Ltd Navghar Cross Road 3 Gopinath Complex Bhayander, Thane, Maharashtra, India – 401105.

Madeline Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

The compliance status of Madeline Pharmaceuticals is compliant as of 01 July 2026. The company is actively filing with the Registrar of Companies.